Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D

被引:23
作者
Hawton, Annie [1 ]
Green, Colin
Telford, Claire
Zajicek, John [2 ]
Wright, Dave [3 ]
机构
[1] Univ Exeter, Hlth Econ Grp, PenCLAHRC, Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England
[2] Univ Plymouth, Peninsula Coll Med & Dent, Clin Neurol Res Grp, Plymouth PL4 8AA, Devon, England
[3] Univ Plymouth, Ctr Hlth & Environm Stat, Plymouth PL4 8AA, Devon, England
关键词
cost-effectiveness; decision making; multiple sclerosis; Quality of life; PREFERENCE-BASED MEASURE; DISEASE QUESTIONNAIRE; INDEX; QLQ-C30; SCORES; SF-36;
D O I
10.1016/j.jval.2012.07.007
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: The 29-item Multiple Sclerosis Impact Scale (MSIS-29) is a psychometrically validated patient-reported outcome measure increasingly used in trials of treatments for multiple sclerosis. However, it is non-preference-based and not amenable for use across policy decision-making contexts. Our objective was to statistically map from the MSIS-29, version 2, to the EuroQol five-dimension (EQ-5D) and the six-dimension health state short form (derived from short form 36 health survey) (SF-6D) to estimate algorithms for use in cost-effectiveness analyses. Methods: The relationships between MSIS-29, version 2, and EQ-5D and SF-6D scores were estimated by using data from a cohort of people with multiple sclerosis in South West England (n = 672). Six ordinary least squares (OLS), Tobit, and censored least adjusted deviation (CLAD) regression analyses were conducted on estimation samples, including the use of subscale and item scores, squared and interaction terms, and demographics. Algorithms from models with the smallest estimation errors (mean absolute error [MAE], root mean square error [RMSE], normalized RMSE) were then assessed by using separate validation samples. Results: Tobit and CLAD. For the EQ-5D, the OLS models including subscale squared terms, and item scores and demographics performed comparably (MAE 0.147, RMSE 0.202 and MAE 0.147, RMSE 0.203, respectively), and estimated scores well up to 3 years post-baseline. Estimation errors for the SF-6D were smaller (OLS model including squared terms: MAE 0.058, RMSE 0.073; OLS model using item scores and demographics: MAE 0.059, RMSE 0.08), and the errors for poorer health states found with the EQ-5D were less pronounced. Conclusions: We have provided algorithms for the estimation of health state utility values, both the EQ-5D and SF-6D, from scores on the MSIS-29, version 2. Further research is now needed to determine how these algorithms perform in practical decision-making contexts, when compared with observed EQ-5D and SF-6D values.
引用
收藏
页码:1084 / 1091
页数:8
相关论文
共 43 条
[1]  
[Anonymous], GUID METH TECHN APPR
[2]  
[Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
[3]  
[Anonymous], 2009, FED REGISTER
[4]  
[Anonymous], 2008, Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee
[5]   Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available) [J].
Ara, Roberta ;
Brazier, John .
VALUE IN HEALTH, 2008, 11 (07) :1131-1143
[6]   Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? [J].
Barton, Garry R. ;
Sach, Tracey H. ;
Jenkinson, Claire ;
Avery, Anthony J. ;
Doherty, Michael ;
Muir, Kenneth R. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2008, 6 (1)
[7]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[8]   A comparison of the EQ-5D and SF-6D across seven patient groups [J].
Brazier, J ;
Roberts, J ;
Tsuchiya, A ;
Busschbach, J .
HEALTH ECONOMICS, 2004, 13 (09) :873-884
[9]  
Brazier J, 2007, REV METHODS MAPPING
[10]  
Brazier J., 2007, MEASURING VALUING HL